Research output per year
Research output per year
Personal profile
Fields of Science
- 317 Pharmacy
International and National Collaboration
Publications and projects within past five years.
-
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy
Eteläinen, T., Silva, M. C., Uhari-Väänänen, J., De Lorenzo, F., Jäntti, M., Cui, H., Chavero-Pieres, M., Kilpeläinen, T., Mechtler, C., Svarcbahs, R., Seppälä, E., Savinainen, J., Puris, E., Fricker, G., Gynther, M., Julku, U., Huttunen, H., Haggarty, S. & Myöhänen, T., 12 Apr 2023, In: Science translational medicine. 15, 691, 10.1126/scitranslmed.abq2915.Research output: Contribution to journal › Article › Scientific › peer-review
-
CDNF rescues motor neurons in models of amyotrophic lateral sclerosis by targeting endoplasmic reticulum stress
De Lorenzo, F., Lüningschrör, P., Nam, J., Beckett, L., Pilotto, F., Galli, E., Lindholm, P., von Collenberg, C. R., Mungwa, S. T., Jablonka, S., Kauder, J., Thau-Habermann, N., Petri, S., Lindholm, D., Saxena, S., Sendtner, M., Saarma, M. & Voutilainen, M. H., 1 Sep 2023, In: Brain : a journal of neurology. 146, 9, p. 3783–3799 17 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Removal of proteinase K resistant alpha Syn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model
Eteläinen, T. S., Kilpeläinen, T. P., Ignatius, A., Auno, S., De Lorenzo, F., Uhari-Väänänen, J. K., Julku, U. H. & Myöhänen, T. T., 1 Nov 2022, In: Neuropharmacology. 218, 15 p., 109213.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Role of CDNF in SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis
Voutilainen, M. H., De Lorenzo, F., Montonen, E., Tuominen, R. K., Lindholm, D., Sendtner, M. & Saarma, M., Apr 2018, In: Cell Transplantation. 27, 4, p. 717-718 2 p.Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access -
Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action
Voutilainen, M. H., De Lorenzo, F., Stepanova, P., Bäck, S., Pulkkila, P., Pörsti, E., Saarma, M., Männistö, P. T. & Tuominen, R. K., 2017, In: eNeuro. 4, 1, 14 p., e0117-16.2017.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
-
Mechanisms of constitutive vs. adaptive immune resistance of treatment persistent residual tumor cells
De Lorenzo, F., Decombis, S. & Mustjoki, S.
Suomen Akatemia Projektilaskutus
01/01/2023 → 31/12/2027
Project: Academy of Finland: Bilateral partnerships, joint calls
-
JAES 2023-2026 MUSTJOKI SATU Discovery o
Awad, S., Bouhlal, J. O. V., De Lorenzo, F., Dufva, O., Huuhtanen, J., Häkkinen, A. A., Peltonen, K. & Mustjoki, S.
01/12/2022 → 31/12/2026
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
CDNF- A novel drug therapy for treatment of ALS
Voutilainen, M., De Lorenzo, F. & Beckett, L.
01/01/2017 → 31/12/2019
Project: University of Helsinki Three-Year Research Project
-
CDNF ja MANF amyotrofisen lateraaliskleroosin geneettisissä malleissa
Voutilainen, M., De Lorenzo, F. & Stepanova, P.
01/09/2014 → 31/08/2017
Project: Research project
-
M.Voutilainen Jane ja Aatos Erkon säätiö
Voutilainen, M., De Lorenzo, F. & Stepanova, P.
01/10/2013 → 30/09/2016
Project: Research project